Aedes-borne arboviruses imposes significant economic and public health costs inAreas covered: We performed a systematic review of the economic evidence surrounding aedes-borne arboviruses and strategies to prevent and control these diseases to inform disease control policy decisions and research directions. We searched four databases covering an 18-year period (2000-2018) to identify arboviral disease-related cost of illness studies, cost studies of vector control and prevention strategies, cost-effectiveness analyses and cost-benefit analyses. We identified 74 published studies that revealed substantial global total costs in yellow fever virus and dengue virus ranging from $2.1 billion - 57.3 billion. Cost studies of vector control and surveillance programs are limited, but a few studies found that costs of vector control programs ranged from $5.62to $73.5 million. Cost-effectiveness evidence was limited across Aedes-borne diseases, but generally found targeted dengue vaccination programs cost-effective. This review revealed insufficient economic evidence for vaccine introduction and implementation of surveillance and vector control programs.Expert opinion: Evidence of the economic burden of aedes-borne arboviruses and the economic impact of strategies for arboviral disease prevention and control is critical to inform policy decisions and to secure continued financial support for these preventive and control measures.

中文翻译：

---

伊蚊传播的虫媒病毒的经济证据和伊蚊传播的虫媒病毒疾病预防和控制策略的回顾。

伊蚊传播的虫媒病毒在以下领域造成了巨大的经济和公共卫生成本：我们对围绕伊蚊传播的虫媒病毒的经济证据以及预防和控制这些疾病的策略进行了系统综述，以为疾病控制政策决策和研究方向提供依据。我们搜索了四个数据库，涵盖了一个为期18年（2000年至2018年）的疾病数据库，以确定与病毒性疾病相关的疾病研究成本，病媒控制和预防策略的成本研究，成本效益分析和成本效益分析。我们确定了74项已发表的研究，这些研究揭示了全球黄热病病毒和登革热病毒的巨额总成本，范围在21亿美元至573亿美元之间。病媒控制和监视程序的成本研究是有限的，但是一些研究发现病媒控制程序的成本在5美元左右。62至7350万美元。在伊蚊传播的各种疾病中，成本效益证据有限，但通常发现针对性的登革热疫苗接种计划具有成本效益。这项审查揭示了缺乏足够的经济证据来证明疫苗的引入以及实施监督和媒介控制程序。专家意见：伊蚊传播的虫媒病毒的经济负担以及预防和控制虫媒病毒策略的经济影响的证据对于为政策决策和决策提供依据至关重要确保为这些预防和控制措施提供持续的财政支持。